Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy
- 03.11.2022
- Research
Erschienen in:
- Verfasst von
- Cleopatra Rutihinda
- Ryma Haroun
- Nour Elhouda Saidi
- Juan Pablo Ordoñez
- Sahar Naasri
- Dominique Lévesque
- François-Michel Boisvert
- Pierre-Hugues Fortier
- Mathieu Belzile
- Laurent Fradet
- Vincent Hubert-Tremblay
- Guy Anne Turgeon
- Chang Shu Wang
- Patrick Delage
- Étienne Rousseau
- Benoît Paquette
- Ayman J. Oweida
- Erschienen in
- Cancer Immunology, Immunotherapy | Ausgabe 5/2023
Abstract
Background
Radioresistance of HNSCCs remains a major challenge for effective tumor control. Combined radiotherapy (RT) and immunotherapy (IT) treatment improved survival for a subset of patients with inflamed tumors or tumors susceptible to RT-induced inflammation. To overcome radioresistance and improve treatment outcomes, an understanding of factors that suppress anti-tumor immunity is necessary. In this regard, regulatory T cells (Tregs) are critical mediators of immune suppression in HNSCCs. In this study, we investigated how radiation modulates Treg infiltration in tumors through the chemokine CCL20. We hypothesized that radiation induces CCL20 secretion resulting in Treg infiltration and suppression of anti-tumor immunity.
Methods
Human and mouse HNSCC cell lines with different immune phenotypes were irradiated at doses of 2 or 10 Gy. Conditioned media, RNA and protein were collected for assessment of CCL20. qPCR was used to determine CCL20 gene expression. In vivo, MOC2 cells were implanted into the buccal cavity of mice and the effect of neutralizing CCL20 antibody was determined alone and in combination with RT. Blood samples were collected before and after RT for analysis of CCL20. Tumor samples were analyzed by flow cytometry to determine immune infiltrates, including CD8 T cells and Tregs. Mass-spectrometry was performed to analyze proteomic changes in the tumor microenvironment after anti-CCL20 treatment.
Results
Cal27 and MOC2 HNSCCs had a gene signature associated with Treg infiltration, whereas SCC9 and MOC1 tumors displayed a gene signature associated with an inflamed TME. In vitro, tumor irradiation at 10 Gy significantly induced CCL20 in Cal27 and MOC2 cells relative to control. The increase in CCL20 was associated with increased Treg migration. Neutralization of CCL20 reversed radiation-induced migration of Treg cells in vitro and decreased intratumoral Tregs in vivo. Furthermore, inhibition of CCL20 resulted in a significant decrease in tumor growth compared to control in MOC2 tumors. This effect was further enhanced after combination with RT compared to either treatment alone.
Conclusion
Our results suggest that radiation promotes CCL20 secretion by tumor cells which is responsible for the attraction of Tregs. Inhibition of the CCR6-CCL20 axis prevents infiltration of Tregs in tumors and suppresses tumor growth resulting in improved response to radiation.
Anzeige
- Titel
- Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy
- Verfasst von
-
Cleopatra Rutihinda
Ryma Haroun
Nour Elhouda Saidi
Juan Pablo Ordoñez
Sahar Naasri
Dominique Lévesque
François-Michel Boisvert
Pierre-Hugues Fortier
Mathieu Belzile
Laurent Fradet
Vincent Hubert-Tremblay
Guy Anne Turgeon
Chang Shu Wang
Patrick Delage
Étienne Rousseau
Benoît Paquette
Ayman J. Oweida
- Publikationsdatum
- 03.11.2022
- Verlag
- Springer Berlin Heidelberg
- Erschienen in
-
Cancer Immunology, Immunotherapy / Ausgabe 5/2023
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851 - DOI
- https://doi.org/10.1007/s00262-022-03313-2
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
